Pharmaceutical and biotechnology companies in Ireland will have a more streamlined route to temperature-controlled European shipping following FedEx’s launch of a digital booking and management portal across 26 markets. The platform connects customers to specialist cold-chain services, helping simplify the logistics behind sensitive medicines, biologics, vaccines and clinical trial shipments.

Announced on 13 October, the portal provides access to FedEx Temp-Assure Advantage and allows customers to onboard, order pre-conditioned packaging, schedule shipments and manage returns online. According to Air Cargo News, the service covers domestic and intra-European shipments in Ireland, Great Britain and 24 other markets. For businesses coordinating time-sensitive deliveries, consolidating these steps within one digital process could reduce administrative friction and make specialist shipping easier to arrange.

The platform builds on FedEx’s established healthcare logistics network, which serves pharmaceutical manufacturers, biotech companies and clinical research organisations. Its Temp-Assure Advantage solution combines qualified packaging with transportation infrastructure designed to maintain specified temperatures throughout transit. The service supports frozen shipments between −25°C and −15°C, refrigerated products at 2°C to 8°C, and controlled room-temperature shipments at 15°C to 25°C. FedEx says its vacuum-insulated packaging and phase-change materials can maintain required temperatures for more than 96 hours. Its healthcare logistics services also cover clinical trial materials, biologics and other sensitive healthcare products.

For Ireland’s life sciences sector, the commercial value lies in improving access to specialised logistics without treating every shipment as a bespoke administrative exercise. Digital booking and returns management can help logistics and supply-chain teams coordinate packaging and transport more efficiently, particularly when handling temperature-sensitive products across multiple European destinations. The service does not guarantee faster delivery or eliminate temperature risk, but it offers a more accessible way to organise shipments using an established specialist network.

The solution also incorporates reusable packaging, with containers collected, refurbished and redeployed. That model can reduce reliance on single-use shipping materials while supporting the performance requirements of cold-chain transport. As pharmaceutical supply chains manage increasingly complex products and distribution needs, combining digital access, qualified packaging and established transport capability gives businesses another option for strengthening operational control.

For the sector, the lesson is direct: making specialist cold-chain logistics easier to book and manage can help Ireland’s pharma and biotech businesses coordinate critical shipments more efficiently, while supporting the integrity of temperature-sensitive products moving through European supply chains.

Source: Air Cargo News / FedEx